<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR144" class="ref">
 <label class="label">144.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Cheng</surname>
    <given-names class="given-names">AL</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hsu</surname>
    <given-names class="given-names">CH</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lin</surname>
    <given-names class="given-names">JK</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hsu</surname>
    <given-names class="given-names">MM</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ho</surname>
    <given-names class="given-names">YF</given-names>
   </name>
   <name class="name">
    <surname class="surname">Shen</surname>
    <given-names class="given-names">TS</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ko</surname>
    <given-names class="given-names">JY</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lin</surname>
    <given-names class="given-names">JT</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lin</surname>
    <given-names class="given-names">BR</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ming-Shiang</surname>
    <given-names class="given-names">W</given-names>
   </name>
   <etal class="etal"/>
  </person-group>
  <article-title class="article-title">Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions</article-title>
  <source class="source">Anticancer Res</source>
  <year class="year">2001</year>
  <volume class="volume">214B</volume>
  <fpage class="fpage">2895</fpage>
  <lpage class="lpage">2900</lpage>
 </element-citation>
</ref>
